Gruppo Lepetit SRL, part of Sanofi, is a company headquartered in Italy. The firm manufactures pharmaceuticals and proprietary medicines, medical and surgical supplies.

The Board of Regents of The University of Texas System, a subsidiary of The University of Texas at Austin, is an American company located in Austin, TX. The firm oversees college activities.

ActivBiotics develops and sells antibiotics and combination therapies for the treatment of acute and chronic infections. The company’s lead product candidate, Rifalazil, is a proprietary, orally administered antibacterial agent which is in a Phase III clinical trial for the treatment of intermittent claudication associated with peripheral arterial disease. The company’s other product candidate, M40403, is a proprietary small molecule to mimic the function of a naturally occurring enzyme, which plays a role in various inflammatory disease states. It also develops ABI-0043 as a proprietary antibacterial agent for the treatment of complicated skin and skin structure infections caused by Staphylococcus aureus, including methicillin-resistant Staphylococcus aureus. In addition, the company identifies product candidates from its proprietary compound libraries for the treatment of inflammatory diseases and bacterial infections. The company’s superoxide dismutases (SOD) mimetic library consists of approximately 250 small molecules that mimic naturally occurring SOD enzymes.

Part of Cosmo Pharmaceuticals NV, Cosmo Technologies Ltd. is an Irish company located in Dublin that manufactures and distributes pharmaceutical products. Salix Pharmaceuticals Ltd., now part of Bausch Health Cos., Inc. acquired Cosmo Technologies Ltd. from Cosmo Pharmaceuticals SA.\nThe company says this about itself: COSMO designs, manufactures and markets family-safe technology products. Committed to the idea that technology should be designed for families, not just repurposed from other segments, COSMO is pioneering new product categories. At the center of its offerings is its mobile application, COSMO: Mission Control. This hub for managing connected devices and family software is meant for families who are seeking a new way of doing technology.

TenNor Therapeutics Suzhou Ltd. manufactures pharmaceutical products. It specializes in research and development of new drugs for the treatment of digestive diseases caused by pathogens, including those resistant to available antibiotics. The company was founded by Zhen Kun Ma in 2013 and is headquartered in Suzhou, China.

Ciba-Geigy AG was manufacturing pharmaceuticals. The company was merged with Sandoz Ltd. to create Novartis AG. The company was founded in 1884 and was headquartered in Basle, Switzerland.

ActivBiotics Pharma LLC is an American private company located in Tucker, GA, involved in commercial physical and biological research.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

Kaneka Corp. engages in the manufacture and sale of chemicals, synthetic resins, and plastics. It operates through the following segments: Material Solutions, Quality of Life Solutions, Health Care Solutions, Nutrition Solutions and Others. The Material Solutions segment covers biodegradable polymers, materials that support the development of social infrastructure and mobility which includes the weight reduction and fuel efficiency improvement. The Quality of Life Solutions segment handles energy saving needs such as housing and living infrastructure, and development of Internet of things (IoT) and artificial intelligence (AI). The Health Care Solutions segment offers solutions through the fusion of devices and medicines, and develops healthcare business based on biopharmaceuticals and regenerative and cellular medicines. The Nutrition Solutions segment provides materials and supplement solutions to food production support in livestock and fishery industries. The Others segment provides agency services for property and life insurance. The company was founded on September 1, 1949 and is headquartered in Osaka, Japan.

Farmitalia Carlo Erba

Alfa Wassermann SpA manufactures pharmaceutical products. Its products include drugs for thromboembolic diseases, for the treatment and prophylaxis of deep-vein thrombosis, and for gastroenteric tract pathologies. The company was founded by Marino Golinelli on January 24, 1948 and is headquartered in Bologna, Italy.

Biofer SpA manufactures and markets pharmaceutical products. Its products includes iron complexes, biological line, steroids, enzymes, folinates, and miscellaneous. The company was founded in 1985 and is headquartered in Medolla, Italy.

Shenyang Fuyang Pharmaceutical Technology Co., Ltd., established on 2016-11-17, Business scope includes drug research and development,retail;Drug R&D Technical Consulting,technology transfer,Technical Services;Business Management Consulting;Self-operated and agent import and export of various commodities and technologies,Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments.)

Chongqing Huabang Shengkai Pharmaceutical Co., Ltd., established on 2009-08-28, Business scope includes licensed projects:pharmaceutical production;Drug import and export;Pharmaceutical commissioned production.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)General project:Medical Research and Experimental Development;Chemical product sales(No licensed chemical products);Manufacturing of basic chemical raw materials(Manufacture of licensed chemicals free of hazardous chemicals).(Except for projects subject to approval by law,Carry out business activities independently in accordance with the law with a business license)

Societ�� Prodotti Antibiotici SpA is a pharmaceutical firm. The company was founded in 1947 and is headquartered in Milan, Italy.

The Texas A&M University System creates a seamless pathway for students to earn an associate and bachelor’s degree in related fields

Heilongjiang Huarui Biotechnology Co., Ltd., established on 2019-08-20, Business scope includesL-Alanine,L-Phenylalanine,Glucosamine Sulfate,riboflavin,Cobalamin,Oxytetracycline base,Oxytetracycline Hydrochloride,Kanamycin,Desmethyltetracycline,Kasugamycin,Spinosad,thuringiencin,Gibberellin,Meva,Lova,Vancomycin,Acarbose,Doxycycline Hydrochloride,Amikacin,Minocycline Hydrochloride,Tigecycline,panthenol,thbrthdrexvbdr,beta-Alanine,biotin,folic acid,taurine,L-carnitine,aspartame,Glufosinate-ammonium,Mesotrione,Penoxsulam,clethodim,Promethazine,Tebuthiauron,imazapyr,Difenoconazole,Fludioxonil,pyraclostrobin,Flusilazole,Azoxystrobin,Trifloxystrobin,Tebuconazole,Prothioconazole,Spiroxamine,imidacloprid,Acetamiprid,Thiamethoxam,Chlorpyrifos,Clothianidin,Chlorantraniliprole,lambda-cyhalothrin,Nitenpyram,quinclorac,kung fu acid,Kung fu permethrin,Bifenthrin,Cyhalofop-methyl,benzsulfonamide,Dimethoxypyrimidine and its chemical intermediates,Pesticide Intermediates,Cream,milk,water dispersible granules,Soluble agent,Granules,Liquid,microemulsion,powder,Dispersible Tablets,Soluble powder,Soluble Granules,wettable powder,Suspending agent,Dispersible liquid,Soluble glue,Oil agent,Suspension Seed Coating,Seed Treatment Dry Powder,Seed treatment liquid and other preparations,Production of Silicone Defoamer,Sales;Operate the company's self-produced products and the machinery and equipment required for production,Import and export business of spare parts and technology(Except for the goods and technologies that the state restricts the company to operate or prohibits the import and export of)

Amyloid Solution is a developer of therapy intended to overcome Alzheimer by developing modifying treatments. The company focuses on pathophysiological events related to disease progression and its underlying mechanism to find novel therapeutics, enabling clients with the best solution for Alzheimer disease.